Tenelia Elderly CGMS Study(TEDDY)

Handok

Status and phase: Completed; Phase 4

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: Teneligliptin; Drug: Placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT03508323

MP_C403

Details and patient eligibility

About

To assess the efficacy and safety of Teneligliptin in Patients aged 65 and Older with inadequately controlled type 2 diabetes.

Full description

To assess the efficacy and safety of Teneligliptin in Patients aged 65 and Older with inadequately controlled type 2 diabetes.

Enrollment: 65 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are 65 years or older on screening
• Patients with type 2 diabetes mellitus
• Patients with 7.0% ≤ HbA1c ≤ 9.0% at the screening visit
• Patients with FPG < 270mg/dL on screening visit

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

65 participants in 2 patient groups, including a placebo group

Teneligliptin

Experimental group

Treatment:

Drug: Teneligliptin

Placebo

Placebo Comparator group

Treatment:

Drug: Placebo